ABSTRACT
In vitro fertilization (IVF) with ovarian stimulation is an effective treatment for
couples needing treatment with assisted reproductive technologies (ART) where polycystic
ovary syndrome (PCOS) is coexisting. However, it is also associated with an increased
risk of ovarian hyperstimulation syndrome.
In vitro maturation (IVM) avoids the risks and side effects of ovarian stimulation
by retrieving immature oocytes from unstimulated ovaries. These immature oocytes are
then cultured, matured, and fertilized in vitro. Embryos are then selected for transfer
in the same manner as conventional IVF. Although there has been significant progress
in terms of improving clinical pregnancy and live-birth rates after IVM, there remains
much to learn in terms of what controls maturation, fertilization, and implantation
rates. This review is intended as an update on the most recent advances and directions
of ongoing research in IVM in patients with PCOS.
KEYWORDS
Assisted reproductive technology - in vitro maturation - polycystic ovary syndrome
REFERENCES
- 1
Child T J, Abdul-Jalil A K, Guleki B et al..
In vitro maturation and fertilization of oocytes from unstimulated normal ovaries,
polycystic ovaries and women with polycystic ovary syndrome.
Fertil Steril.
2001;
76
936-942
- 2
MacDougall M J, Tan S L, Balen A et al..
A controlled study comparing patients with and without polycystic ovaries undergoing
in-vitro fertilization.
Hum Reprod.
1993;
8
233-237
- 3
Ludwig M, Finas D F, Al-Hasani S et al..
Oocyte quality and treatment outcome in intracytoplasmic injection cycles of polycystic
ovarian syndrome patients.
Hum Reprod.
1999;
14
354-358
- 4
Cha K Y, Koo J J, Ko J J et al..
Pregnancy after in vitro fertilization of human follicular oocytes collected from
nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte
program.
Fertil Steril.
1991;
55
109-113
- 5
Trounson A, Wood C, Kausche A.
In vitro maturation and the fertilization and developmental competence of oocytes
recovered from untreated polycystic ovarian patients.
Fertil Steril.
1994;
62
353-362
- 6
Andersen A N, Gianaroli L, Felberbaum R et al..
Assisted reproductive technology in Europe, 2003. Results generated from European
registers by ESHRE.
Hum Reprod.
2007;
22
1513-1525
- 7 SART .National statistics for ART. http://Available at: www.sartonline.com
- 8
Tan S L, Child T J, Guleki B.
In vitro maturation and fertilization of oocytes from unstimulated ovaries: predicting
the number of immature oocytes retrieved by early follicular phase ultrasonography.
Am J Obstet Gynecol.
2002;
186
684-689
- 9
Rao G D, Tan S L.
In vitro maturation of oocytes.
Semin Reprod Med.
2005;
23
242-247
- 10
Al-Sunaidi M, Tulandi T, Holzer H et al..
Repeated pregnancies and live births after in vitro maturation treatment.
Fertil Steril.
2007;
87
1212. e9-e12
- 11
Chian R C, Buckett W M, Tulandi T et al..
Prospective randomized study of human chorionic gonadotrophin priming before immature
oocyte retrieval from unstimulated women with polycystic ovarian syndrome.
Hum Reprod.
2000;
15
165-170
- 12
Chian R C, Buckett W M, Too L L et al..
Pregnancies resulting from in vitro matured oocytes retrieved from patients with polycystic
ovary syndrome after priming with human chorionic gonadotropin.
Fertil Steril.
1999;
72
639-642
- 13
Lin Y H, Hwang J L, Huang L W et al..
Combination of FSH priming and HCG priming for in-vitro maturation of human oocytes.
Hum Reprod.
2003;
18
1632-1636
- 14
Chian R C, Guleki B, Buckett W M et al..
Priming with human chorionic gonadotropin before retrieval of immature oocytes in
women with infertility due to the polycystic ovary syndrome.
N Engl J Med.
1999;
341
1624-1626
- 15
Son W Y, Yoon S H, Lim J H.
Effect of gonadotropin priming on in-vitro maturation of oocytes collected from women
at risk of OHSS.
Reprod Biomed Online.
2006;
13
340-348
- 16
Chian R C.
In-vitro maturation of immature oocytes for infertile women with PCOS.
Reprod Biomed Online.
2004;
8
547-552
- 17
Soderstrom-Anttila V, Makinen S, Tuuri T et al..
Favourable pregnancy rates with insemination of in vitro matured oocytes from unstimulated
patients.
Hum Reprod.
2005;
20
1534-1540
- 18
Mikkelsen A L, Lindenberg S.
Benefit of FSH priming of women with PCOS to the in vitro maturation procedure and
the outcome: a randomized prospective study.
Reproduction.
2001;
122
587-592
- 19
Requena A, Neuspiller F, Cobo A C et al..
Endocrinological and ultrasonographic variations after immature oocyte retrieval in
a natural cycle.
Hum Reprod.
2001;
16
1833-1837
- 20
Child T J, Guleki B, Sylvestre C et al..
Ultrasonographic assessment of endometrial receptivity at embryo transfer in an in
vitro maturation of oocyte program.
Fertil Steril.
2003;
79
656-658
- 21
Noyes N, Liu H C, Schattman G et al..
Endometrial thickness appears to be a significant factor in embryo implantation in
in-vitro fertilization.
Hum Reprod.
1995;
10
919-922
- 22
Chian R C, Buckett W M, Tan S L.
In-vitro maturation of human oocytes.
Reprod Biomed Online.
2004;
8
148-166
- 23
Tan S L, Child T J.
In vitro maturation of oocytes from unstimulated polycystic ovaries.
Reprod Biomed Online.
2001;
4(Suppl 1)
18-23
- 24
Child T J, Phillips S J, Abdul-Jalil A K et al..
A comparison of in vitro maturation and in vitro fertilization for women with polycystic
ovaries.
Obstet Gynecol.
2002;
100
665-670
- 25
Le Du A, Kadoch I J, Bourcigaux N et al..
in vitro maturation fro the treatment of infertility associated with polycystic ovarian
syndrome: the French experience.
Hum Reprod.
2005;
20
420-424
- 26
Papanikolaou E G, Platteau P, Albano C et al..
Immature oocyte in-vitro maturation: clinical aspects.
Reprod Biomed Online.
2005;
10
587-592
- 27
Cha K Y, Chung H M, Lee D R et al..
Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation
and in vitro fertilization-embryo transfer.
Fertil Steril.
2005;
83
1461-1465
- 28
Soderstrom-Anttila V, Salokorpi T, Pihlaja M et al..
Obstetric and perinatal outcome and preliminary results of development of children
born after in vitro maturation of oocytes.
Hum Reprod.
2006;
21
1508-1513
- 29
Buckett W, Chian R C, Holzer H et al..
Congenital abnormalities and perinatal outcome in pregnancies following IVM, IVF,
and ICSI delivered in a single center.
Fertil Steril.
2006;
85(Suppl 2)
s11-s12
, (abst)
- 30
Li Y, Feng H L, Cao Y J et al..
Confocal microscopic analysis of the spindle and chromosome configurations of human
oocytes matured in vitro.
Fertil Steril.
2006;
85
827-832
William BuckettM.D.
Department of Obstetrics and Gynecology, McGill University, Royal Victoria Hospital
687 Pine Avenue West, Montreal, Quebec H3A 1A1, Canada
Email: william.buckett@muhc.mcgill.ca